ClinicalTrials.gg
Not yet recruitingNCT07922499Updated Nov 6, 2026

Adapting an Evidence-Based Physical Activity Intervention to Prevent Frailty and Functional Decline in Older Women Living With HIV

An interventional study of Positively Fit and Strong! in Mobility Impairment and Frailty, sponsored by University of Illinois Chicago. Not yet recruiting. Open to female participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by University of Illinois Chicago · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
50 Years to 100 Years
Sex
Female
01

Study summary

This study will examine the effectiveness and implementation of a physical activity and health education intervention by comparing outcomes of participants in the intervention group to those in a control group.

Read the detailed description

Older women living with HIV (OWWH) experience early onset and accelerated progression of geriatric syndromes, including musculoskeletal pain, functional decline, and frailty, than the general population, placing them at heightened risk for falls, disability, loss of independence, and reduced quality of life. These aging-related conditions are compounded by multimorbidity, long-term HIV treatment effects, HIV-related stigma, and social and structural factors that limit access to and sustained engagement in evidence-based health promotion programs. Interventions that preserve physiologic reserve, maintain strength and mobility, and slow frailty progression are critical to supporting healthy aging in this growing and understudied population. Physical activity programs that combine strength training, balance, and behavior change strategies effectively improve function and reduce frailty risk among older adults; however, such programs have not been rigorously adapted or tested for OWWH whose physical and psychosocial contexts of aging differ from those of the general population. The goal of this study is to adapt and test the Fit \& Strong! (F\&S) evidence-based physical activity and education intervention to address HIV-specific physical, psychosocial, and contextual needs of women, aged 50 years and older, living with HIV. The tailored intervention will integrate group-based physical activity and behavior change strategies, fostering social support and empowerment while addressing modifiable individual-, interpersonal-, and community-level implementation determinants identified by OWWH as influencing program participation and maintenance. Using a community-engaged approach, this study will: 1) collaborate with a Community Advisory Board of OWWH to tailor the F\&S program using the ADAPT-ITT model and pilot test the new intervention; 2) conduct a fully powered randomized waitlist-controlled trial with 210 participants to evaluate the intervention's impact on participant health outcomes; and 3) assess implementation outcomes, including acceptability, feasibility, fidelity, and sustainability, at the participant, instructor, and organizational levels. By targeting modifiable mechanisms of functional decline through an evidence-based group intervention, this project addresses a critical public health gap and has the potential to preserve functional independence and improve aging trajectories among women aging with HIV.

02

Conditions studied

  • Mobility Impairment
  • Frailty

Browse trials for

03

In context

Frailty

1,284 studies on the registry are indexed under Frailty; 452 are open to participants now.

This study's planned enrollment of 210 is above the median of 81 across 767 interventional studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

University of Illinois Chicago is the lead sponsor of 20 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:women must be aged 50 or older, have , currently taking ART, and speak and read adequate English to fill out the surveys and understand class instructions.

-

Exclusion Criteria:We will exclude all individuals with moderate or high risk for of possible injury or death when undertaking strenuous or maximal exercise using a modified Physical Activity Readiness Questionnaire (PAR-Q)73; this is a simple, 7-item self-reported screening tool for determining safety and possible risk (i.e. heart, bone, joint conditions) for starting a PA program that will be administered during enrollment screening. If a participant verbally responds 'YES' to items 1-4, we will ask for physician's approval prior to participation. Other key exclusion criteria include: (1) current participation in any organized physical activity program; (2) significant cognitive impairment or severe psychiatric illness that would preclude safe consent or adherence. Recruiters will be trained to recognize signs of mental stress and will immediately contact a project physician (French, Collison) as needed. We also have relationships with mental health providers at CORE and if one of our clinicians thinks it is necessary the recruiter will accompany the person to the ER; (3) pregnant; and (4) substance use will only be an exclusion if it is felt to impact the safety of participants

-

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Intervention

    Will receive the physical activity and health intervention and provide measurements at specified time periods

    Behavioral: Positively Fit and Strong!

  • Other
    Control

    The control participants will take all measurements and then, after those have been completed, will receive the intervention later. A waitlist control.

    Behavioral: Positively Fit and Strong!

Interventions

  • BehavioralPositively Fit and Strong!

    A 12 week (2 x week) class with 60 minutes of combined aerobic and strength training and 30 minutes of health education

06

What researchers measure

Primary outcomes

  1. Lower Extremity Leg Strength Using Sit-to-Stand

    Chair-stand test: number of sit-to-stands in 30 seconds

    Time frame: Baseline, 3, 6 and 9 mos

Secondary outcomes

  1. Pain

    Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 5-question subscale measures pain; LE stiffness and function also measured

    Time frame: Baseline, 3, 6, and 9 months

07

Study locations

No study locations are listed for this record.

08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2027; primary completion for May 2030, 35 months later.

Of 513 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 35 months is above that.

Counting every sponsor, half of 517 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartEst.
Jun 2027
Primary completionEst.
May 2030
CompletionEst.
May 2030
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07922499
Lead sponsor
University of Illinois Chicago
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Jun 2027 (estimated)
Primary completion
May 2030 (estimated)
Completion
May 2030 (estimated)
Last update
Nov 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion